Andra Ap Fonden Neurocrine Biosciences Inc Transaction History

Andra Ap Fonden

$6.89 Billion
Q2 2025

A detailed history of Andra Ap Fonden transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Andra Ap Fonden holds 27,400 shares of NBIX stock, worth $3.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

27,400

Previous 89,100 69.25%

Holding current value

$3.78 Million

Previous $9.85 Million 65.06%

% of portfolio

0.05%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$87.54 - $128.18 $5.4 Million - $7.91 Million	-61,700 Reduced 69.25%	27,400 $3.44 Million
Q1 2025 May 13, 2025	SELL	$107.22 - $153.29 $1.2 Million - $1.72 Million	-11,200 Reduced 11.17%	89,100 $9.85 Million
Q4 2024 Feb 07, 2025	SELL	$111.62 - $139.44 $8.66 Million - $10.8 Million	-77,600 Reduced 43.62%	100,300 $13.7 Million
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $1.9 Million - $2.54 Million	16,600 Added 10.29%	177,900 $20.5 Million
Q2 2024 Aug 07, 2024	BUY	$130.86 - $143.19 $11.4 Million - $12.4 Million	86,900 Added 116.8%	161,300 $22.2 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $208,640 - $229,984	1,600 Added 2.2%	74,400 $10.3 Million
Q4 2023 Feb 15, 2024	BUY	$106.07 - $132.76 $1.93 Million - $2.42 Million	18,200 Added 33.33%	72,800 $9.59 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $1.25 Million - $1.56 Million	-13,300 Reduced 19.59%	54,600 $6.14 Million
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $3 Million - $3.51 Million	-33,500 Reduced 33.04%	67,900 $6.4 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $818,757 - $1.07 Million	8,700 Added 9.39%	101,400 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $3.63 Million - $4.32 Million	34,000 Added 57.92%	92,700 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $1.09 Million - $1.27 Million	11,800 Added 25.16%	58,700 $6.24 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $1.65 Million - $2.18 Million	-21,800 Reduced 31.73%	46,900 $4.57 Million
Q4 2021 Feb 15, 2022	BUY	$79.65 - $106.22 $1.37 Million - $1.83 Million	17,200 Added 33.4%	68,700 $5.85 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $370,574 - $425,829	-4,300 Reduced 7.71%	51,500 $4.94 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $4 Million - $4.57 Million	44,700 Added 402.7%	55,800 $5.43 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $437,849 - $597,000	-5,000 Reduced 31.06%	11,100 $1.08 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $738,735 - $920,805	8,500 Added 111.84%	16,100 $1.54 Million
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $2.25 Million - $3.16 Million	-23,400 Reduced 75.48%	7,600 $731,000
Q2 2020 Aug 06, 2020	BUY	$85.09 - $130.36 $365,887 - $560,548	4,300 Added 16.1%	31,000 $3.78 Million
Q1 2020 May 13, 2020	BUY	$75.11 - $113.76 $277,907 - $420,912	3,700 Added 16.09%	26,700 $2.31 Million
Q4 2019 Feb 10, 2020	BUY	$86.8 - $118.57 $2 Million - $2.73 Million	23,000 New	23,000 $2.47 Million

Others Institutions Holding NBIX

# of Institutions

681

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account